无创脑刺激对自杀意念疗效的网络Meta分析
网络1(3项RCT)中加速TMS与假刺激无差异;网络2(25项RCT)中双颞ECT优于假刺激;网络3(5项RCT)中左侧DLPFC重复TMS联合艾司西酞普兰显著减少SI。
要点
- 双颞电休克治疗(ECT)在跨诊断人群中减少自杀意念优于假刺激。
- 左侧DLPFC重复TMS联合艾司西酞普兰较假TMS联合SSRI显著减少自杀意念。
- 无惊厥性NIBS单用不联合药物时,对自杀意念的疗效不优于假刺激。
核心结论
- 双颞ECT和高频重复TMS联合SSRI是改善自杀意念的有效干预,而无惊厥性NIBS不联合药物治疗不优于假刺激。
研究设计与样本
- 系统综述与网络Meta分析,检索Embase、MEDLINE、PsycINFO、CINAHL和Cochrane CENTRAL至2023年3月,纳入至少一个NIBS臂且报告自杀相关结局的RCT。
主要发现
- 网络1中加速TMS作用于左侧DLPFC与假TMS无差异。
- 网络2中双颞ECT优于假刺激减少自杀意念,其他NIBS干预均不优于假NIBS。
- 网络3中左侧DLPFC重复TMS联合艾司西酞普兰较假TMS联合SSRI显著减少自杀意念。
关键数值与推荐
- 网络1(3项RCT)使用加速TMS刺激左侧DLPFC,与假TMS无差异。
- 网络2(25项RCT)双颞ECT优于假刺激;其他NIBS不优于假NIBS。
- 网络3(5项RCT)左侧DLPFC重复TMS联合艾司西酞普兰优于假TMS联合SSRI。
临床怎么用
- 对伴有自杀意念的精神科患者,可考虑双颞ECT或高频重复TMS联合SSRI作为改善自杀意念的干预。
- 无惊厥性NIBS不联合药物治疗时,不应期望其优于假刺激来减少自杀意念。
局限性
- 网络1和网络3纳入研究数量少。
- 网络2研究设计和自杀意念结局指标异质性大。
- 网络2和网络3主要聚焦于治疗抑郁症患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Noninvasive brain stimulation (NIBS) holds promise for reducing suicidal ideation (SI), but its cross-diagnostic efficacy remains unexamined. This systematic review and network meta-analysis examined the comparative efficacy of NIBS interventions on SI across psychiatric conditions and the lifespan. METHODS: The authors searched Embase, MEDLINE, PsycINFO, CINAHL, and the Cochrane CENTRAL Database from inception to March 2023 for randomized controlled trials (RCTs) with at least one NIBS arm and an outcome from the suicide item of a standardized measure or a suicide-specific measure. Studies that focused solely on invasive stimulation or excluded participants with SI were ineligible. Network meta-analyses examined the comparative efficacy of NIBS for treating SI, using standardized mean differences (Hedges' g). Analyses were first restricted to RCTs that recruited participants with SI at baseline (network 1), then were conducted on all identified RCTs (network 2), and, finally, were conducted to examine NIBS plus pharmacotherapy initiation (network 3). RESULTS: Seventy-five studies met inclusion criteria for the systematic review, and 58 were included in meta-analyses. Studies in network 1 (three RCTs) used accelerated transcranial magnetic stimulation (TMS) over the left dorsolateral prefrontal cortex (DLPFC); no difference from sham TMS was found. In network 2 (25 RCTs), bitemporal electroconvulsive therapy (ECT) was favorable compared to sham stimulation for reducing SI, and all other NIBS interventions showed no benefit over sham NIBS. In network 3 (five RCTs), left DLPFC repetitive TMS plus escitalopram significantly reduced SI compared to sham TMS plus a selective serotonin reuptake inhibitor (SSRI). CONCLUSIONS: Although the findings were limited by small numbers of studies in networks 1 and 3, large heterogeneity in study design and SI outcomes in network 2, and a focus mostly on treating patients with depression in networks 2 and 3, they support bitemporal ECT and high-frequency repetitive TMS combined with SSRIs as effective interventions for improving SI, and nonconvulsive NIBS without pharmacotherapy shows no benefit over sham NIBS.
引用
- Traynor JM, Koudys JW, Weichel M, et al. The Comparative Efficacy of Noninvasive Brain Stimulation for Suicidal Ideation: A Network Meta-Analysis. Am J Psychiatry. 2026. PMID: 41992095. doi:10.1176/appi.ajp.20250753
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。